Early Life and Family
Erich von Baumbach, born into the von Baumbach family, is part of a lineage deeply connected to Boehringer Ingelheim, a pharmaceutical giant. His family's involvement in the company dates back to its founding in 1885 by Albert Boehringer. Erich is one of the 15 family members who own equal parts of the company.
Rise to Success
Erich's wealth is directly linked to his stake in Boehringer Ingelheim, a company that has grown from a regional chemical producer to a global pharmaceutical leader. The company's success is built on innovations in respiratory medicine, animal health, and oncology.
Key Business Strategies
Boehringer Ingelheim, under the leadership of family members like Erich, has focused on long-term goals, including substantial investments in research and development, which account for nearly 20% of the company's annual revenue. The company's private status shields it from short-term market pressures, allowing for a focus on innovation and strategic growth.
Philanthropy
The Boehringer and von Baumbach families are deeply committed to philanthropy, supporting scientific research, education, public health, and environmental sustainability. The Boehringer Ingelheim Foundation funds various initiatives in these areas.
